Abstract
Blood pressure and pulse rate were studied in 20 Parkinsonian patients on no treatment, and during treatment with bromocriptine (mean dosage 148 mg/day) as the sole anti-Parkinsonian therapy. The drug was shown to reduce erect systolic and diastolic and supine systolic blood pressure and to increase erect pulse rate, in a predictable dose-dependent manner. The occurrence of episodes of significant postural hypotension was less predictable and was a transitory phenomenon in all patients. Peripheral dopamine receptor blockade with domperidone did not alter the findings, suggesting that the principal mechanism for these cardiovascular effects is a central dopaminergic one.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agid Y., Barroche G., Bonnet A. M., Javoy-Agid F., Kato G., Lhermitte F., Pollak P., Signoret J. L. Dopamine receptor stimulating agonists in the treatment of Parkinson's disease. Biomedicine. 1979 Jun;30(2):67–71. [PubMed] [Google Scholar]
- Agid Y., Pollak P., Bonnet A. M., Signoret J. L., Lhermitte F. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet. 1979 Mar 17;1(8116):570–572. doi: 10.1016/s0140-6736(79)91003-1. [DOI] [PubMed] [Google Scholar]
- Calne D. B., Teychenne P. F. L-DOPA effect on blood pressure in man. Prog Brain Res. 1977;47:331–336. doi: 10.1016/S0079-6123(08)62737-5. [DOI] [PubMed] [Google Scholar]
- Leibowitz M., Lieberman A. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's disease. Neurology. 1975 Oct;25(10):917–921. doi: 10.1212/wnl.25.10.917. [DOI] [PubMed] [Google Scholar]
- Parkes J. D., Debono A. G., Marsden C. D. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1101–1108. doi: 10.1136/jnnp.39.11.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poliomyelitis vaccines. Lancet. 1977 Jul 2;2(8027):21–22. [PubMed] [Google Scholar]
- Reid J. L., Calne D. B., George C. F., Vakil S. D. The action of L(-)-dopa on baroreflexes in Parkinsonism. Clin Sci. 1972 Dec;43(6):851–859. doi: 10.1042/cs0430851. [DOI] [PubMed] [Google Scholar]
- Teychenne P. F., Leigh P. N., Reid J. L., Calne D. B., Greenacre J. K., Petrie A., Bamji A. N. Idiopathic parkinsonism treated with bromocriptine. Lancet. 1975 Sep 13;2(7933):473–476. doi: 10.1016/s0140-6736(75)90546-2. [DOI] [PubMed] [Google Scholar]
- Watanabe A. M., Chase T. N., Cardon P. V. Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes. Clin Pharmacol Ther. 1970 Sep-Oct;11(5):740–746. doi: 10.1002/cpt1970115740. [DOI] [PubMed] [Google Scholar]